Invesco’s Achieve Life Sciences ACHV Stock Holding History

Invesco’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Buy	+42,292	New	+$202K	﹤0.01%	3469
2025 Q2	–	Sell	-73,644	Closed	-$197K	–	3759
2025 Q1	$197K	Buy	73,644 +56,856	+339%	+$177K	﹤0.01%	3513
2024 Q4	$59.1K	Buy	16,788 +715	+4%	+$3.24K	﹤0.01%	3677
2024 Q3	$76.2K	Sell	16,073 -141	-0.9%	-$644	﹤0.01%	3650
2024 Q2	$76.2K	Buy	+16,214	New	+$78.1K	﹤0.01%	3783

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invesco's ACHV Position: Q2 2026 in Review

Invesco opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 42,292 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #3469 among its holdings. This is a return to the name: Invesco previously reported a position in ACHV as recently as Q1 2025.

Invesco first reported a position in ACHV in Q2 2024 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Invesco held 42,292 shares of Achieve Life Sciences worth $276K as of Q2 2026.
Achieve Life Sciences was a new Invesco position in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3469 holding.
Invesco first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 5 quarters since.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.